Polypharmacy during pregnancy and associated risk factors : a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019
| dc.contributor.author | Subramanian, Anuradhaa | |
| dc.contributor.author | Azcoaga-Lorenzo, Amaya | |
| dc.contributor.author | Anand, Astha | |
| dc.contributor.author | Phillips, Katherine | |
| dc.contributor.author | Lee, Siang Ing | |
| dc.contributor.author | Cockburn, Neil | |
| dc.contributor.author | Fagbamigbe, Adeniyi Francis | |
| dc.contributor.author | Damase-Michel, Christine | |
| dc.contributor.author | Yau, Christopher | |
| dc.contributor.author | McCowan, Colin | |
| dc.contributor.author | O'Reilly, Dermot | |
| dc.contributor.author | Santorelli, Gillian | |
| dc.contributor.author | Hope, Holly | |
| dc.contributor.author | Kennedy, Jonathan I | |
| dc.contributor.author | Abel, Kathryn M | |
| dc.contributor.author | Eastwood, Kelly-Ann | |
| dc.contributor.author | Locock, Louise | |
| dc.contributor.author | Black, Mairead | |
| dc.contributor.author | Loane, Maria | |
| dc.contributor.author | Moss, Ngawai | |
| dc.contributor.author | Plachcinski, Rachel | |
| dc.contributor.author | Thangaratinam, Shakila | |
| dc.contributor.author | Brophy, Sinead | |
| dc.contributor.author | Agrawal, Utkarsh | |
| dc.contributor.author | Vowles, Zoe | |
| dc.contributor.author | Brocklehurst, Peter | |
| dc.contributor.author | Dolk, Helen | |
| dc.contributor.author | Nelson-Piercy, Catherine | |
| dc.contributor.author | Nirantharakumar, Krishnarajah | |
| dc.contributor.author | MuM-PreDiCT Group | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Evaluation | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Women’s Health Research | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2023-01-18T11:17:01Z | |
| dc.date.available | 2023-01-18T11:17:01Z | |
| dc.date.issued | 2023-01-16 | |
| dc.description | Acknowledgements Not applicable. Funding This work was funded by the Strategic Priority Fund “Tackling multimorbidity at scale” programme [grant number MR/W014432/1] delivered by the Medical Research Council and the National Institute for Health Research in partnership with the Economic and Social Research Council and in collaboration with the Engineering and Physical Sciences Research Council. BT was funded by the National Institute for Health Research (NIHR) West Midlands Applied Research Collaboration. AA, KP and SIL were funded as NIHR Academic Clinical Fellows. The views expressed are those of the authors and not necessarily those of the funders, the NIHR or the UK Department of Health and Social Care. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 13 | |
| dc.format.extent | 1376818 | |
| dc.identifier | 226259935 | |
| dc.identifier | dc14c824-8924-48f5-998a-2802ba089bf3 | |
| dc.identifier | 36647047 | |
| dc.identifier | 85146353108 | |
| dc.identifier.citation | Subramanian, A, Azcoaga-Lorenzo, A, Anand, A, Phillips, K, Lee, S I, Cockburn, N, Fagbamigbe, A F, Damase-Michel, C, Yau, C, McCowan, C, O'Reilly, D, Santorelli, G, Hope, H, Kennedy, J I, Abel, K M, Eastwood, K-A, Locock, L, Black, M, Loane, M, Moss, N, Plachcinski, R, Thangaratinam, S, Brophy, S, Agrawal, U, Vowles, Z, Brocklehurst, P, Dolk, H, Nelson-Piercy, C, Nirantharakumar, K & MuM-PreDiCT Group 2023, 'Polypharmacy during pregnancy and associated risk factors : a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019', BMC medicine , vol. 21, no. 1, 21. https://doi.org/10.1186/s12916-022-02722-5 | en |
| dc.identifier.doi | 10.1186/s12916-022-02722-5 | |
| dc.identifier.iss | 1 | en |
| dc.identifier.issn | 1741-7015 | |
| dc.identifier.other | ORCID: /0000-0002-8109-1930/work/126803771 | |
| dc.identifier.uri | https://hdl.handle.net/2164/19853 | |
| dc.identifier.vol | 21 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | BMC medicine | en |
| dc.subject | Multiple medications | en |
| dc.subject | Polypharmacy | en |
| dc.subject | Medications | en |
| dc.subject | Prescriptions | en |
| dc.subject | Pregnancy | en |
| dc.subject | Multimorbidity | en |
| dc.subject | Multiple long-term conditions | en |
| dc.subject | R Medicine | en |
| dc.subject | National Institute for Health Research (NIHR) | en |
| dc.subject | Supplementary Information | en |
| dc.subject.lcc | R | en |
| dc.title | Polypharmacy during pregnancy and associated risk factors : a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019 | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Subramanian_etal_BMCM_Polypharmacy_During_Pregnancy_VoR.pdf
- Size:
- 1.31 MB
- Format:
- Adobe Portable Document Format
